🇺🇸 MRK — Merck & Co., Inc.

Healthcare Compra
← Volver

Precio actual

148,46 USD

Máx. histórico

156,92

14 días

Split 1048:1000 del 03/06/2021

Caída desde máximo

-5,39%

Rango 52 semanas

77,58 – 156,92

Variación hoy

-1,24%

Cierre anterior

150,33

Rango de hoy

146,28 – 149,59

Volumen hoy

10.884.998

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
118,77 (puede no estar actualizado)
Dividend yield
2,26% (puede no estar actualizado)
Precio objetivo analistas
150,42 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 9 horas
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,3600 USD · Yield: 2,26%
Fecha de pago Importe por participación
13/06/2011 0,3626 USD
11/03/2011 0,3626 USD
13/12/2010 0,3626 USD
13/09/2010 0,3626 USD
11/06/2010 0,3626 USD
11/03/2010 0,3626 USD
11/12/2009 0,3626 USD
02/09/2009 0,3626 USD
04/06/2009 0,3626 USD
04/03/2009 0,3626 USD
03/12/2008 0,3626 USD
03/09/2008 0,3626 USD
04/06/2008 0,3626 USD
05/03/2008 0,3626 USD
05/12/2007 0,3626 USD
Splits Registrados en el histórico de precios
Fecha Ratio
03/06/2021 1048:1000
17/02/1999 2:1
26/05/1992 3:1
26/05/1988 3:1
27/05/1986 2:1
01/06/1972 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
06/03/1998 59,34 61,13 59,34 60,77 +2,98% 3,02% 4.049.682
05/03/1998 59,28 60,29 59,01 59,01 -0,95% 2,16% 5.268.086
04/03/1998 60,03 60,20 59,43 59,58 -1,53% 1,29% 3.748.067
03/03/1998 60,44 61,19 60,26 60,50 +0,00% 1,53% 3.537.629
02/03/1998 60,86 61,13 60,35 60,50 -0,59% 1,27% 3.398.245
27/02/1998 60,29 61,01 60,23 60,86 +1,24% 1,29% 4.257.605
26/02/1998 60,65 61,13 59,73 60,11 -0,69% 2,31% 4.350.667
25/02/1998 61,49 61,49 60,26 60,53 -0,83% 1,99% 5.640.336
24/02/1998 61,58 62,02 60,83 61,04 -2,06% 1,94% 7.039.626
23/02/1998 60,23 62,44 60,23 62,32 +4,76% 3,66% 10.153.024
20/02/1998 58,41 59,61 57,82 59,49 +1,99% 3,06% 6.607.221
19/02/1998 58,62 58,98 58,24 58,33 -1,61% 1,27% 4.737.589
18/02/1998 57,31 59,28 57,07 59,28 +3,65% 3,85% 8.216.320
17/02/1998 56,45 57,64 56,30 57,19 +1,86% 2,38% 7.864.192
13/02/1998 55,76 56,24 55,58 56,15 -0,11% 1,18% 3.363.451
12/02/1998 56,06 56,51 55,22 56,21 +0,27% 2,29% 4.770.286
11/02/1998 56,30 56,30 55,43 56,06 +0,05% 1,54% 4.496.968
10/02/1998 55,58 56,18 55,28 56,03 +1,46% 1,61% 6.192.213
09/02/1998 54,75 55,22 54,12 55,22 +1,31% 2,02% 4.062.467
06/02/1998 54,09 55,16 53,94 54,51 +0,88% 2,26% 5.407.261
05/02/1998 55,22 55,28 53,67 54,03 -1,52% 2,92% 5.604.914
04/02/1998 54,99 55,13 54,63 54,87 -1,08% 0,92% 4.089.506
03/02/1998 55,94 55,94 54,57 55,46 -1,27% 2,45% 7.522.334
02/02/1998 57,25 57,34 56,18 56,18 +0,32% 2,03% 7.056.603
30/01/1998 56,06 56,12 55,64 56,00 -0,42% 0,85% 4.463.642
29/01/1998 56,06 56,77 55,73 56,24 +0,21% 1,86% 6.800.891
28/01/1998 55,11 56,57 55,02 56,12 +2,73% 2,81% 8.948.034
27/01/1998 54,09 55,58 53,97 54,63 +0,44% 2,98% 8.033.549
26/01/1998 54,39 54,84 54,21 54,39 +0,94% 1,15% 4.305.813
23/01/1998 54,21 54,27 52,99 53,88 +0,28% 2,37% 5.152.387